Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaghayegh Nouruzi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Endocrinology|January 31, 2023
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate CancerShaghayegh Nouruzi, Nakisa Tabrizian, Amina Zoubeidi
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 24, 2026
Meeting report: 10th Annual Canadian Conference on EpigeneticsShaghayegh Nouruzi, Sabrina Grégoire, Mathieu Lupien, et al.
EMBO Molecular Medicine|August 4, 2025
New frontiers in prostate cancer treatment from systemic therapy to targeted therapyShaghayegh Nouruzi, Maxim Kobelev, Nakisa Tabrizian, et al.
Oncology Reports|August 12, 2024
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, et al.
Scientific Reports|November 25, 2018
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate CancerDaksh Thaper, Sepideh Vahid, Ramandeep Kaur, et al.
JCI Insight|October 29, 2024
ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancerShaghayegh Nouruzi, Takeshi Namekawa, Nakisa Tabrizian, et al.
Cell Reports|August 8, 2023
ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancerNakisa Tabrizian, Shaghayegh Nouruzi, Cassandra Jingjing Cui, et al.
Nature Communications|April 28, 2022
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancerShaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Endocrinology|January 31, 2023
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate CancerShaghayegh Nouruzi, Nakisa Tabrizian, Amina Zoubeidi
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 24, 2026
Meeting report: 10th Annual Canadian Conference on EpigeneticsShaghayegh Nouruzi, Sabrina Grégoire, Mathieu Lupien, et al.
EMBO Molecular Medicine|August 4, 2025
New frontiers in prostate cancer treatment from systemic therapy to targeted therapyShaghayegh Nouruzi, Maxim Kobelev, Nakisa Tabrizian, et al.
Oncology Reports|August 12, 2024
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, et al.
Scientific Reports|November 25, 2018
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate CancerDaksh Thaper, Sepideh Vahid, Ramandeep Kaur, et al.
JCI Insight|October 29, 2024
ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancerShaghayegh Nouruzi, Takeshi Namekawa, Nakisa Tabrizian, et al.
Cell Reports|August 8, 2023
ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancerNakisa Tabrizian, Shaghayegh Nouruzi, Cassandra Jingjing Cui, et al.
Nature Communications|April 28, 2022
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancerShaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Pageof 1